Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Laboratory Automated Incubators
... at a CAGR of 4.0% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$399.4 Million by ... Read More
-
Mice Model
... CAGR of 5.3% over the analysis period 2024-2030. CRISPR / CAS9 Technology, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$976.7 Million by the end of ... Read More
-
Mycotoxin Testing
... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Nuclear Medicine Radioisotope
... at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m) Radioisotope, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end ... Read More
-
Plasma Therapy
... CAGR of 7.4% over the analysis period 2024-2030. Pure PRP, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$468.4 Million by the end of the analysis ... Read More
-
Preclinical Imaging (In-VIVO)
... at a CAGR of 4.8% over the analysis period 2024-2030. Preclinical Imaging Modalities, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$900.1 Million by the end ... Read More
-
Predictive and Presymptomatic Testing
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 12.7% CAGR The Predictive and Presymptomatic Testing market ... Read More
-
Protein Binding Assays
... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end ... Read More
-
Radiography Test Equipment
... at a CAGR of 8.2% over the analysis period 2024-2030. Computed Tomography Technology, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$858.1 Million by the end ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis ... Read More
-
Pregnancy Detection Kits
... at a CAGR of 4.8% over the analysis period 2024-2030. Home Pregnancy Tests (HPT), one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$805.2 Million by the ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
In Vitro Diagnostics (IVD) Quality Control
... reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More
-
Medical Imaging Phantoms
... at a CAGR of 6.0% over the analysis period 2024-2030. X-Ray Device, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$95.9 Million by the end of ... Read More
-
MRI-Guided Neurosurgical Ablation
... at a CAGR of 6.7% over the analysis period 2024-2030. RF Ablation Systems, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$301.7 Million by the end ... Read More
-
Microtomes
... 6.0% over the analysis period 2024-2030. Microtome Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth ... Read More
-
Medical Imaging Workstations
... at a CAGR of 6.8% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$3.8 Billion by the end of ... Read More
-
Molecular Quality Controls
... at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of ... Read More
-
Atomic Spectroscopy
... CAGR of 6.9% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Testing Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by the end ... Read More
-
ATP Assay
... CAGR of 7.1% over the analysis period 2024-2030. ATP Assay Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by the end ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Bioanalytical Testing Services
... at a CAGR of 7.0% over the analysis period 2024-2030. Small Molecule Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.7 Billion by the end ... Read More
-
Preimplantation Genetic Testing
... at a CAGR of 10.1% over the analysis period 2024-2030. Preimplantation Genetic Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million ... Read More
-
Rapid Microbiology Testing
... at a CAGR of 7.5% over the analysis period 2024-2030. Rapid Microbiology Testing Instruments, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.9 Billion by the ... Read More
Research Assistance
